Regenerative and protective effects of dMSC-sEVs on high-glucose-induced senescent fibroblasts by suppressing RAGE pathway and activating Smad pathway.
Diabetic wounds
Fibroblasts
High-glucose
Senescence
Small extracellular vesicles
Journal
Stem cell research & therapy
ISSN: 1757-6512
Titre abrégé: Stem Cell Res Ther
Pays: England
ID NLM: 101527581
Informations de publication
Date de publication:
29 04 2020
29 04 2020
Historique:
received:
25
01
2020
accepted:
17
04
2020
revised:
31
03
2020
entrez:
1
5
2020
pubmed:
1
5
2020
medline:
22
6
2021
Statut:
epublish
Résumé
Fibroblasts are crucial for supporting normal wound healing. However, the functional state of these cells is impaired in diabetics because of a high-glucose (HG) microenvironment. Small extracellular vesicles (sEVs) have emerged as a promising tool for skin wound treatment. The aim of this study was to investigate the effects of sEVs derived from human decidua-derived mesenchymal stem cells (dMSC-sEVs) on HG-induced human dermal fibroblast (HDF) senescence and diabetic wound healing and explore the underlying mechanism. We first created a HDF senescent model induced by HG in vitro. dMSC-conditioned medium (dMSC-CM) and dMSC-sEVs were collected and applied to treat the HG-induced HDFs. We then examined the proliferation, migration, differentiation, and senescence of these fibroblasts. At the same time, the expressions of RAGE, p21 RAS, Smad2/3, and pSmad2/3 were also analyzed. Furthermore, pSmad2/3 inhibitor (SB431542) was used to block the expression of pSmad2/3 to determine whether dMSC-sEVs improved HDF senescence by activating Smad pathway. Finally, we assessed the effect of dMSC-sEVs on diabetic wound healing. The HG microenvironment impaired the proliferation, migration, and differentiation abilities of the HDFs and accelerated their senescence. dMSC-CM containing sEVs improved the proliferation and migration abilities of the HG-induced fibroblasts. dMSC-sEVs internalized by HG-induced HDFs not only significantly promoted HDF proliferation, migration, and differentiation, but also improved the senescent state. Furthermore, dMSC-sEVs inhibited the expression of RAGE and stimulated the activation of Smad signaling pathway in these cells. However, SB431542 (pSmad2/3 inhibitor) could partially alleviate the anti-senescent effects of dMSC-sEVs on HG-induced HDFs. Moreover, the local application of dMSC-sEVs accelerated collagen deposition and led to enhanced wound healing in diabetic mice. The detection of PCNA, CXCR4, α-SMA, and p21 showed that dMSC-sEVs could enhance HDF proliferation, migration, and differentiation abilities and improve HDF senescent state in vivo. dMSC-sEVs have regenerative and protective effects on HG-induced senescent fibroblasts by suppressing RAGE pathway and activating Smad pathway, thereby accelerating diabetic wound healing. This indicates that dMSC-sEVs may be a promising candidate for diabetic wound treatment.
Sections du résumé
BACKGROUND
Fibroblasts are crucial for supporting normal wound healing. However, the functional state of these cells is impaired in diabetics because of a high-glucose (HG) microenvironment. Small extracellular vesicles (sEVs) have emerged as a promising tool for skin wound treatment. The aim of this study was to investigate the effects of sEVs derived from human decidua-derived mesenchymal stem cells (dMSC-sEVs) on HG-induced human dermal fibroblast (HDF) senescence and diabetic wound healing and explore the underlying mechanism.
METHODS
We first created a HDF senescent model induced by HG in vitro. dMSC-conditioned medium (dMSC-CM) and dMSC-sEVs were collected and applied to treat the HG-induced HDFs. We then examined the proliferation, migration, differentiation, and senescence of these fibroblasts. At the same time, the expressions of RAGE, p21 RAS, Smad2/3, and pSmad2/3 were also analyzed. Furthermore, pSmad2/3 inhibitor (SB431542) was used to block the expression of pSmad2/3 to determine whether dMSC-sEVs improved HDF senescence by activating Smad pathway. Finally, we assessed the effect of dMSC-sEVs on diabetic wound healing.
RESULTS
The HG microenvironment impaired the proliferation, migration, and differentiation abilities of the HDFs and accelerated their senescence. dMSC-CM containing sEVs improved the proliferation and migration abilities of the HG-induced fibroblasts. dMSC-sEVs internalized by HG-induced HDFs not only significantly promoted HDF proliferation, migration, and differentiation, but also improved the senescent state. Furthermore, dMSC-sEVs inhibited the expression of RAGE and stimulated the activation of Smad signaling pathway in these cells. However, SB431542 (pSmad2/3 inhibitor) could partially alleviate the anti-senescent effects of dMSC-sEVs on HG-induced HDFs. Moreover, the local application of dMSC-sEVs accelerated collagen deposition and led to enhanced wound healing in diabetic mice. The detection of PCNA, CXCR4, α-SMA, and p21 showed that dMSC-sEVs could enhance HDF proliferation, migration, and differentiation abilities and improve HDF senescent state in vivo.
CONCLUSION
dMSC-sEVs have regenerative and protective effects on HG-induced senescent fibroblasts by suppressing RAGE pathway and activating Smad pathway, thereby accelerating diabetic wound healing. This indicates that dMSC-sEVs may be a promising candidate for diabetic wound treatment.
Identifiants
pubmed: 32349787
doi: 10.1186/s13287-020-01681-z
pii: 10.1186/s13287-020-01681-z
pmc: PMC7191792
doi:
Substances chimiques
Culture Media, Conditioned
0
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
166Références
Nat Rev Cancer. 2015 Jul;15(7):397-408
pubmed: 26105537
J Mol Histol. 2017 Apr;48(2):121-132
pubmed: 28229263
J Clin Endocrinol Metab. 2008 Apr;93(4):1143-52
pubmed: 18182449
Curr Protoc Cell Biol. 2006 Apr;Chapter 3:Unit 3.22
pubmed: 18228490
Wound Repair Regen. 2020 Jan;28(1):16-25
pubmed: 31270882
PLoS One. 2011;6(8):e22865
pubmed: 21826213
Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9363-7
pubmed: 7568133
J Cell Biochem. 2019 Jun;120(6):10847-10854
pubmed: 30681184
J Periodontol. 2006 Aug;77(8):1289-303
pubmed: 16881798
J Periodontol. 2013 Mar;84(3):379-88
pubmed: 22554295
Biomaterials. 2017 Jul;133:70-81
pubmed: 28433939
Ann Dermatol. 2017 Dec;29(6):667-687
pubmed: 29200755
Cytotherapy. 2017 Mar;19(3):371-383
pubmed: 28081982
Cell Tissue Res. 2019 May;376(2):233-245
pubmed: 30610451
Stem Cells Int. 2017;2017:3738071
pubmed: 28337222
Endocrinology. 2001 Mar;142(3):1234-41
pubmed: 11181540
Organogenesis. 2015;11(4):183-206
pubmed: 26652928
Stem Cells Int. 2018 Jul 25;2018:5420463
pubmed: 30147728
Int J Mol Med. 2018 Jan;41(1):473-484
pubmed: 29115383
Diabetes Care. 2006 Jun;29(6):1420-32
pubmed: 16732039
PLoS One. 2008 Apr 02;3(4):e1886
pubmed: 18382669
Foot Ankle Surg. 2017 Dec;23(4):215-224
pubmed: 29202978
Sci Rep. 2016 Sep 12;6:32993
pubmed: 27615560
Lab Med. 2015 Fall;46(4):277-84
pubmed: 26489671
Blood. 2013 Jul 25;122(4):491-8
pubmed: 23673863
J Tissue Eng Regen Med. 2019 Apr;13(4):555-568
pubmed: 30656863
Am J Pathol. 2003 Jan;162(1):303-12
pubmed: 12507913
Wound Repair Regen. 2009 Sep-Oct;17(5):739-49
pubmed: 19769726
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):E968-77
pubmed: 26858453
Exp Dermatol. 2010 Dec;19(12):1088-95
pubmed: 20701629
Int Rev Cytol. 2007;257:143-79
pubmed: 17280897
J Cell Sci. 2010 May 15;123(Pt 10):1603-11
pubmed: 20445011
Am J Pathol. 2001 Aug;159(2):513-25
pubmed: 11485910
Adv Skin Wound Care. 2018 May;31(5):225-233
pubmed: 29672394
Wound Repair Regen. 2020 May;28(3):315-325
pubmed: 31943524
J Transl Med. 2009 Mar 17;7:17
pubmed: 19292913
Expert Rev Proteomics. 2018 Oct;15(10):801-808
pubmed: 30253662
Stem Cell Res Ther. 2017 Oct 3;8(1):219
pubmed: 28974256